Literature DB >> 12695425

Global risk of cardiovascular disease.

N Poulter1.   

Abstract

UK death rates from coronary heart disease are among the highest in the world. This is because the UK has high levels of standard risk factors and a low level of intervention on those risk factors. The most important modifiable cardiovascular risk factors are dyslipidaemia (particularly high LDL cholesterol and low HDL cholesterol), smoking, hypertension, glucose intolerance, and central obesity. Intervention strategies that do not target those individuals at highest cardiovascular risk are likely to be less cost effective. Global risk estimation is increasingly recognised by management guidelines as a clinically and cost effective means of guiding treatment. However, an over reliance on short term absolute risk may result in under treatment of young people (particularly women) at high relative risk and over treatment of older people (particularly men) at low relative risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695425      PMCID: PMC1876298          DOI: 10.1136/heart.89.suppl_2.ii2

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  8 in total

1.  Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.

Authors:  I U Haq; L E Ramsay; W W Yeo; P R Jackson; E J Wallis
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

2.  Identifying men at high risk of heart attacks: strategy for use in general practice.

Authors:  A G Shaper; S J Pocock; A N Phillips; M Walker
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

3.  Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.

Authors:  Gerd Assmann; Paul Cullen; Helmut Schulte
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

Review 4.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Authors:  L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell
Journal:  J Hum Hypertens       Date:  1999-09       Impact factor: 3.012

5.  The Dundee coronary risk-disk for management of change in risk factors.

Authors:  H Tunstall-Pedoe
Journal:  BMJ       Date:  1991-09-28

Review 6.  Fetal origins of coronary heart disease.

Authors:  D J Barker
Journal:  BMJ       Date:  1995-07-15

Review 7.  Evidence from randomised trials on the long-term effects of hormone replacement therapy.

Authors:  Valerie Beral; Emily Banks; Gillian Reeves
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321

8.  High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.

Authors:  M Barbir; D Wile; I Trayner; V R Aber; G R Thompson
Journal:  Br Heart J       Date:  1988-11
  8 in total
  20 in total

1.  Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom.

Authors:  Thomas M MacDonald; Steven V Morant
Journal:  Br J Clin Pharmacol       Date:  2008-02-14       Impact factor: 4.335

2.  Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative.

Authors:  Sheldon W Tobe; James A Stone; Melissa Brouwers; Onil Bhattacharyya; Kimberly M Walker; Martin Dawes; Jacques Genest; Steven Grover; Gordon Gubitz; David Lau; Andrew Pipe; Peter Selby; Mark S Tremblay; Darren E R Warburton; Richard Ward; Vincent Woo; Lawrence A Leiter; Peter P Liu
Journal:  CMAJ       Date:  2011-09-12       Impact factor: 8.262

3.  Additional benefit of yoga to standard lifestyle modification on blood pressure in prehypertensive subjects: a randomized controlled study.

Authors:  Ramkumar Thiyagarajan; Pravati Pal; Gopal Krushna Pal; Senthil Kumar Subramanian; Madanmohan Trakroo; Zachariah Bobby; Ashok Kumar Das
Journal:  Hypertens Res       Date:  2014-09-04       Impact factor: 3.872

Review 4.  Role of computed tomography in risk assessment for coronary heart disease.

Authors:  Tarun K Mittal; Mahmoud Barbir; Michael Rubens
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

5.  Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk.

Authors:  F El Fakiri; M A Bruijnzeels; A W Hoes
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

6.  Caffeic Acid Protects against Iron-Induced Cardiotoxicity by Suppressing Angiotensin-Converting Enzyme Activity and Modulating Lipid Spectrum, Gluconeogenesis and Nucleotide Hydrolyzing Enzyme Activities.

Authors:  Veronica F Salau; Ochuko L Erukainure; Md Shahidul Islam
Journal:  Biol Trace Elem Res       Date:  2020-06-06       Impact factor: 3.738

7.  Stressful life events, sexual orientation, and cardiometabolic risk among young adults in the United States.

Authors:  Mark L Hatzenbuehler; Natalie Slopen; Katie A McLaughlin; Kate A McLaughlin
Journal:  Health Psychol       Date:  2014-08-18       Impact factor: 4.267

8.  Improving mortality prediction using biosocial surveys.

Authors:  Noreen Goldman; Dana A Glei; Yu-Hsuan Lin; Maxine Weinstein
Journal:  Am J Epidemiol       Date:  2009-01-15       Impact factor: 4.897

9.  Blood pressure in adult rural INDEPTH population in Asia.

Authors:  Hoang Van Minh; Kusol Soonthornthada; Nawi Ng; Sanjay Juvekar; Abdur Razzaque; Ali Ashraf; Syed Masud Ahmed; Tran Huu Bich; Uraiwan Kanungsukkasem
Journal:  Glob Health Action       Date:  2009-09-28       Impact factor: 2.640

10.  Missed opportunities for coronary heart disease diagnoses: primary care experience.

Authors:  Mehtap Turkay; Yesim Senol; Mustafa Kemal Alimoglu; Mehmet R Aktekin; Necmi Deger
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.